NECROSIS OBSERVED ON CT ENHANCEMENT IS OF PROGNOSTIC VALUE IN SOFT-TISSUE SARCOMA

被引:1
作者
GUSTAFSON, P
HERRLIN, K
BILING, L
WILLEN, H
RYDHOLM, A
机构
[1] UNIV LUND HOSP,DEPT ORTHOPED,S-22185 LUND,SWEDEN
[2] UNIV LUND HOSP,DEPT DIAGNOST RADIOL,S-22185 LUND,SWEDEN
[3] UNIV LUND HOSP,DEPT PATHOL & CYTOL,S-22185 LUND,SWEDEN
关键词
SARCOMA; SOFT TISSUE; CT; NEOPLASMS;
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Fifty-one patients with deep-seated soft tissue sarcoma of the extremities and trunk wall were examined with contrast-enhanced CT for presence of nonenhanced tumor areas (CT necrosis). After a median follow-up time of 3 years, 19 of the 41 patients with CT necrosis had developed metastases, compared to none of the 10 patients who had tumors without CT necrosis. Tumors with CT necrosis were larger than tumors without. but in tumors of similar size, absence of CT necrosis was a favorable prognostic sign.
引用
收藏
页码:474 / 476
页数:3
相关论文
共 50 条
[21]   Neoadjuvant or Adjuvant Chemotherapy in Soft-Tissue Sarcoma? [J].
Remiszewski, Piotr ;
Filipek, Kinga ;
Pisklak, Agata ;
Chmiel, Paulina ;
Rutkowski, Piotr ;
Czarnecka, Anna M. .
CURRENT ONCOLOGY REPORTS, 2025, 27 (05) :491-515
[22]   Recent advances in radiotherapy for soft-tissue sarcoma [J].
Brian O’sullivan ;
Iain Ward ;
Charles Catton .
Current Oncology Reports, 2003, 5 (4) :274-281
[23]   Hyperthermia as an adjunctive treatment for soft-tissue sarcoma [J].
Pennacchioli, Elisabetta ;
Fiore, Marco ;
Gronchi, Alessandro .
EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (02) :199-210
[24]   Non-rhabdomyosarcoma soft-tissue sarcoma [J].
Milgrom, Sarah A. ;
Million, Lynn ;
Mandeville, Henry ;
Safwat, Akmal ;
Ermoian, Ralph P. ;
Terezakis, Stephanie .
PEDIATRIC BLOOD & CANCER, 2021, 68
[25]   Isolated limb perfusion with melphalan and tumor necrosis factor α for advanced melanoma and soft-tissue sarcoma [J].
Hayes, Andrew J. ;
Neuhaus, Susan J. ;
Clark, Matthew A. ;
Thomas, J. Meirion .
ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (01) :230-238
[26]   Isolated Limb Perfusion With Melphalan and Tumor Necrosis Factor α for Advanced Melanoma and Soft-Tissue Sarcoma [J].
Andrew J. Hayes ;
Susan J. Neuhaus ;
Matthew A. Clark ;
J. Meirion Thomas .
Annals of Surgical Oncology, 2007, 14 :230-238
[27]   Prognostic factors in soft tissue sarcoma [J].
Levine, EA .
SEMINARS IN SURGICAL ONCOLOGY, 1999, 17 (01) :23-32
[28]   EDATREXATE IN PATIENTS WITH SOFT-TISSUE SARCOMA - ACTIVITY IN MALIGNANT FIBROUS HISTIOCYTOMA [J].
CASPER, ES ;
CHRISTMAN, KL ;
SCHWARTZ, GK ;
JOHNSON, B ;
BRENNAN, MF ;
BERTINO, JR .
CANCER, 1993, 72 (03) :766-770
[29]   Delay in referral to a specialist soft-tissue sarcoma unit [J].
Clark, MA ;
Thomas, JM .
EJSO, 2005, 31 (04) :443-448
[30]   Trends in Survival for Patients With Metastatic Soft-Tissue Sarcoma [J].
Italiano, Antoine ;
Mathoulin-Pelissier, Simone ;
Le Cesne, Axel ;
Terrier, Philippe ;
Bonvalot, Sylvie ;
Collin, Francoise ;
Michels, Jean-Jacques ;
Blay, Jean-Yves ;
Coindre, Jean-Michel ;
Bui, Binh .
CANCER, 2011, 117 (05) :1049-1054